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Local synthesis of immunoglobulin G (IgG) in the central nervous system was investigated in 10 patients
with tuberculous meningitis (TBM), 15 patients with aseptic meningitis (AM), and 15 patients with pulmonary
tuberculosis only (PTBO). The IgG synthesis rate for patients with TBM was 56.4 6 18.9 mg/day (mean 6
standard deviation), which was significantly higher than that for patients with AM (8.0 6 6.7 mg/day, P <
0.001) and that for patients with PTBO (7.5 6 4.4 mg/day, P < 0.001). Therefore, the increased IgG synthesis
rate in the central nervous system provided supporting evidence for differentiating the diagnosis of TBM from
that of AM (sensitivity, 100%; specificity, 83.3%). Simultaneous measurement by enzyme-linked immunosor-
bent assay of IgG seroreactivity to lipoarabinomannan and purified protein derivative antigens in cerebrospi-
nal fluid (CSF) demonstrated seropositivity in all 6 patients with TBM, 4 of 15 patients with AM, and 4 of 10
patients with PBTO. All patients showing false-positive reactivity in CSF demonstrated seropositivity in sera
and normal ranges for IgG synthesis rates in CSF. Also, the semiquantitive measurement of IgG antibody (Ab)
titers in these patients demonstrated higher IgG Ab titers in serum than in CSF except for one patient with a
highly elevated albumin quotient, suggesting a leaky blood-brain barrier. The results strongly suggested that
the Mycobacterium tuberculosis-specific IgG Abs were diffusible through the blood-brain barrier, which ad-
dresses the pitfall of serological tests for the early diagnosis of TBM. The serological detection of IgG Abs to
lipoarabinomannan and purified protein derivative antigens in CSF could be misleading in the presence of
simultaneously elevated levels of IgG Abs in serum.
Tuberculous meningitis (TBM) is still a serious cause of
morbidity and mortality in developing nations. Previous clini-
cal studies of TBM have clearly demonstrated that the timing
of treatment is the most critical factor affecting the ultimate
outcome, which stresses the importance of early diagnosis of
TBM (11).
Among the various methods recently developed for the early
diagnosis of TBM, enzyme-linked immunosorbent assay
(ELISA) for the detection of antibodies (Ab) to Mycobacte-
rium tuberculosis antigens (Ag) in cerebrospinal fluid (CSF)
has been the most widely investigated (2, 4, 8, 9). ELISA is
technically simple and inexpensive, and the results can be ob-
tained on the day of testing. The central nervous system (CNS)
is immunologically secured, bacterial contaminations are ab-
sent in CSF, and a nontuberculous mycobacterial meningitis is
extremely rare, all of which provide further advantages for the
serodiagnosis of TBM.
Previous clinical trials of M. tuberculosis-specific Ab detec-
tion in CSF by ELISA demonstrated its clinical usefulness for
the early diagnosis of TBM; however, occasional false-positive
results have been reported (3, 6, 16, 22). Although the reasons
for the false-positive results have not been thoroughly investi-
gated yet, the possibility of passive transfer of Ab from serum
to CSF is critical in determining the diagnostic utility of
ELISA, especially in areas of endemic tuberculosis where a
large population is seropositive for M. tuberculosis-specific Ag.
For further evaluation of the dynamics of humoral Ab to M.
tuberculosis-specific Ag in TBM, we investigated the status of
de novo synthesis of immunoglobulin G (IgG) in the CNS and
serological Ab detection by ELISA in both serum and CSF for
three patient groups: those with TBM, those with aseptic men-
ingitis (AM), and those with pulmonary tuberculosis only
(PTBO).
(This report was presented at the 118th Annual Meeting of
the American Neurological Association, 17 to 20 October
1993, Boston, Mass.)
MATERIALS AND METHODS
Patients. All patients with meningitis admitted to the neurology ward of
Yonsei University Severance Hospital from March 1992 to August 1993 had
lumbar punctures for diagnostic purposes and at least one computerized tomog-
raphy brain scan before the lumbar puncture. Routine CSF examinations in-
cluded cell count with differential, protein measurement, glucose measurement,
direct smear and culture for acid-fast bacillus, Gram stain and culture for bac-
teria, India ink preparation and cryptococcal antigen test, direct smear and
culture for fungus, and Venereal Disease Research Laboratory test. Patients with
PTBO were admitted to the pulmonary ward, and a diagnostic lumbar puncture
was conducted for the evaluation of headaches or other minor neurological
complaints. Blood was collected from each patient by venipuncture at the time of
lumbar puncture.
(i) TBM.All patients presented with clinical symptoms and signs of meningitis.
Positive acid-fast bacillus smear or culture of M. tuberculosis from CSF was
considered definite evidence of TBM. For patients with no microbiological evi-
dence, TBM was diagnosed when the CSF examination showed findings charac-
teristic of TBM, such as lymphocytosis or elevated protein level and low glucose
level, and at least three of following minor criteria were met: (i) subacute onset
of symptoms (ii) characteristic features of computerized tomography brain scan
(e.g., basal leptomeningeal enhancement, acute hydrocephalus, or a tuberculo-
ma-like lesion), (iii) presence of systemic tuberculosis (TB), (iv) history of ex-
posure toM. tuberculosis, (v) evidence of cranial nerve dysfunction, (vi) favorable
clinical response to antituberculosis medications.
(ii) AM. A diagnosis of AM was made when the following criteria were
* Corresponding author. Mailing address: Yonsei University Col-
lege of Medicine, Severance Hospital CPO Box 8044, Seoul, Korea.
Phone: 02-361-5464. Fax: 02-393-0705.
361
satisfied: (i) clinical signs of meningitis, (ii) characteristic CSF features (e.g.,
mildly increased levels of monocytosis and protein and normal glucose level),
(iii) negative microbiological studies of CSF, (iv) spontaneous improvement with
only conservative management, (v) no evidence of active pulmonary or extrapul-
monary TB.
(iii) PTBO. All patients with PTBO tested positive by sputum smear or culture
for acid-fast bacillus, and chest X rays of these patients revealed active lesions.
A few patients complained of mild dull headaches, but meningeal irritation signs
were absent. CSF examination was essentially normal for all patients.
IgG synthesis rate and AQ. Quantitative immunoelectrophoresis of simulta-
neously collected CSF and serum was conducted with a Behring nephelometer.
IgG synthesis rates were calculated by the following formula (7, 19, 20):




3 0.43 3 5 (mg/day)
The albumin quotients (AQ) were calculated as (albuminCSF/albuminserum) 3
1,000. In these formulas, IgGCSF and albuminCSF are levels of IgG and albumin
in CSF, respectively, and IgGserum and albuminserum are levels of IgG and
albumin in serum, respectively.
IgG reactivity to PPD and LAM Ag. For all patients, initial lumbar puncture
was performed on the first day of hospitalization. Samples of serum (10 ml) and
CSF (3 ml) were obtained, centrifuged at 3,000 rpm for 30 min, and stored at
2208C. The ELISA described by Voller et al. (21) was employed with minor
modifications and was described in detail in our previous study (16). Briefly, 50
ml each of diluted purified protein derivative (PPD) (10 mg/ml) and lipoarabi-
nomannan (LAM) (0.2 mg/ml) was added to the wells of U-bottom microtiter
plates (Dynatech Laboratories, Inc., Chantilly, Va.) and incubated overnight at
378C in a moist chamber. The wells were then washed with phosphate-buffered
saline solution containing 0.05% Tween 20 (PBST) and blocked by the addition
of 100 ml of PBST–0.05% bovine serum albumin at 378C for 1 h. After the wells
were emptied, 50 ml of serum diluted 1:300 or CSF diluted 1:5 in PBST–5%
normal goat serum (Gibco Laboratories, Grand Island, N.Y.) was added to the
wells, which were incubated at 378C for 90 min. After the wells were washed, 50
ml of affinity-purified peroxidase-conjugated goat anti-human IgG (Behring Di-
agnostic, Inc., San Diego, Calif.) diluted 1:5,000 in PBST–5% normal goat serum
was added, and incubation was continued at 378C for 1 h. After another washing,
50 ml of the substrate solution, H2O2–o-phenylenediamine, was added to the
wells, which were incubated at room temperature for about 15 min. The reaction
was then stopped with 50 ml of 2.5 N H2SO4, and the A490 was read. Each test was
performed in duplicate, and the mean absorbance of wells without Ag was
subtracted from those of wells with PPD or LAM Ag before analysis. The cutoff
point for seropositivity was determined by the following formula: upper fourth1
(2 3 interquartile range). The cutoff points for both PPD and LAM were 0.2 in
serum and 0.15 in CSF. The degree of IgG Ab reactivity to PPD and LAM Ag
was expressed according to optical density on a scale of 2 to 111.
Statistical analysis.We used the Mann-Whitney U Wilcoxon rank sum W test
because the values in each group did not have a normal distribution.
RESULTS
Among 10 patients with TBM, three were culture positive
for M. tuberculosis. The CSF features of the remaining seven
patients were quite characteristic of TBM: lymphocytosis
(range, 120 to 430), elevated protein level (180 to 1,200 mg%),
and decreased glucose level (10 to 45 mg%). Chest X rays
showed active pulmonary TB lesions in three patients. Com-
puterized tomography brain scan revealed evidence of hydro-
cephalus in two patients and basal meningeal enhancement in
another three patients. Five patients showed cranial nerve dys-
function on examination. None of the 15 patients with AM
showed any abnormal neurologic deficits, and all 15 spontane-
ously recovered.
IgG synthesis rate. IgG synthesis rates for patients with
TBM varied from 34.3 to 89.0 mg/day (mean, 56.4 mg/day),
which were markedly greater than the mean IgG synthesis rate
for patients with AM (7.5 mg/day; range, 1.3 to 33.3 mg/day) or
PTBO (8.0 mg/day; range, 2.9 to 18.2 mg/day), which was
statistically significant (P, 0.001). However, the IgG synthesis
rate for patients with AM was not significantly different from
that for patients with PTBO. When we considered the mean
plus 2 standard deviations of values for PTBO patients as the
upper limit of the control IgG synthesis rate, only 2 of 15
patients with AM showed abnormally increased IgG synthesis
rates, compared with abnormal increases in all 10 patients with
TBM (Table 1).
AQ. The AQ, indicating the permeability of the blood-brain
barrier (BBB), was also markedly increased for patients with
TBM (mean, 40.3), compared with that of patients with AM
(mean, 11.6) or PTBO (mean, 3.5), which was highly significant
(P , 0.001). The AQ for patients with AM was slightly more
elevated than that for patients with PTBO but was not statis-
tically significant (P . 0.05). If we consider the mean plus 2
standard deviations of the AQ for patients with PTBO as the

















































Mean 6 SD 56.4 6 18.7d 40.3 6 32.1d
a GSR, IgG synthesis rate.
b Value above the mean 1 2 standard deviations for PTBO patients.
c All patients with TBM had IgG synthesis rates and AQ above the mean 1 2
standard deviations for PTBO patients.
d P , 0.001 compared with values for the PTBO group.
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upper limit of normal AQ (i.e.,.7.1), 7 of 15 patients with AM
and all 10 patients with TBM showed evidence of abnormally
increased permeability of the BBB (Table 1).
IgG Ab to M. tuberculosis Ag (LAM and PPD). IgG serore-
activity to PPD and LAM Ag in CSF and serum was measured
by ELISA for 6 of 10 patients with TBM, all 15 patients with
AM, and 10 of 15 patients with PTBO (Table 2).
In serum, IgG Ab to PPD was detected in 9 of 10 patients
with PTBO, 5 of 6 patients with TBM, and 4 of 15 patients with
AM. IgG Ab to LAM Ag was detected in all 10 patients with
PTBO, 4 of 6 patients with TBM, and 9 of 15 patients with AM.
Therefore, either PPD Ag- or LAM Ag-specific IgG Ab was
detected in all (100%) patients with PTBO, 5 of 6 (83.3%)
patients with TBM, and 10 of 15 (66.7%) patients with AM.
IgG Ab to PPD Ag in CSF was present in 4 of 10 (40%)
patients with PTBO, 1 of 15 (6.7%) patients with AM, and 5 of
6 (83.3%) patients with TBM. IgG Ab to LAM Ag was present
in CSF in 2 of 10 (20%) patients with PTBO, 3 of 15 (20%)
patients with AM, and 4 of 6 (66.7%) patients with TBM.
Therefore, IgG Ab reactive to either PPD or LAM Ag was
present in CSF in 4 of 10 (40%) patients with PTBO, 4 of 15
(26.7%) patients with AM, and all 6 (100%) patients with
TBM. These figures showed that the sensitivity and specificity
of assays for CSF Ab to PPD Ag were 83.3% and 80.0%,
respectively, and that those of assays for CSF Ab to LAM Ag
were 66.7% and 80.0%, respectively.
The semiquantitative data for IgG Ab reactivity to PPD and
LAM Ag showed that all four patients (PTBO) with IgG Ab in
CSF had moderately to markedly elevated IgG Ab titers in
serum, which may suggest the passive transfer of IgG Ab
through the intact BBB from serum to CSF. Interestingly, two
patients with moderate titers of IgG Ab to both PPD and LAM
Ag in serum had Ab reactivity to only PPD in CSF. On the
other hand, two other patients with high titers of Ab to both
LAM and PPD Ag in serum had positive reactions to both Ag
in CSF. These findings may suggest that an Ab reactive to PPD
Ag is more permeative than an Ab to LAM Ag. Four patients
with AM who were positive for IgG Ab reactive to either PPD
or LAM Ag in CSF had positive IgG Ab to corresponding Ag
in serum. One patient with CSF IgG Ab to PPD Ag had highly
elevated Ab titers in serum, and 3 patients with CSF IgG Ab to
LAM Ag had mildly, moderately, and markedly elevated Ab
titers in serum. In addition, all four patients with false-positive
results for CSF had abnormally elevated AQ but normal
ranges of IgG synthesis rates.
DISCUSSION
The rationale of the serological diagnosis of TBM by ELISA
is based on the assumption of local synthesis of humoral Ab
against M. tuberculosis Ag in the CNS. Malashkhia and
Geladze (15) reported active PPD-induced transformation of
CSF lymphocytes into B cells in patients with TBM. Plouffe
(17) and Kinnman et al. (12) reported higher rates of prolif-
eration of CSF lymphocytes than of peripheral blood lympho-
cytes after stimulation with PPD. Kinnman et al. (13) and
Sindic et al. (18) demonstrated the presence of an oligoclonal
band in the CSF of patients with TBM, which corresponded to
the IgG Ab against M. tuberculosis Ag or bacillus Calmette-
Guérin (BCG) Ag. The increased IgG synthesis rate and IgG
index in CSF in patients with TBM were also demonstrated by
Kinnman et al. (12) and Kalish et al. (9). In addition, previous
clinical investigations clearly demonstrated the presence of Ab
reactive to various M. tuberculosis Ag in CSF from a large
percentage of patients with TBM in the absence of specific Ab
in serum (16). Therefore, there is little doubt that TBM elicits
local production of M. tuberculosis Ag-specific humoral Ab in
the CNS.
However, as suggested by occasional false-positive results in
our previous clinical investigation (16) and others (1, 6, 10, 22),
it is not necessarily true that the serological tests detect onlyM.
tuberculosis-specific Ab locally produced in the CNS. Immu-
noglobulins in serum may diffuse into CSF through the BBB or
may be actively secreted by the choroidal plexus. In fact, oli-
goclonal band assays of samples from patients with various
systemic inflammatory illnesses have shown the presence of
identical patterns in both serum and CSF, which suggested the
passive penetration of immunoglobulins through the BBB
from serum to CSF (5, 14, 23). In that situation, the diagnostic
utility of serological tests for TBM may depend upon the pres-
ence or absence of serum Ab in the patients being tested,
which has not been adequately studied in previous investiga-
tions. Especially in areas with a high prevalence of TB, the
TABLE 2. IgG Ab reactivities to PPD and LAM Ag





PPD LAM PPD LAM
PTBO
1 2 1 2 2
2 1 1 2 2
3 1 1 2 2
4 1 1 2 2
5 1 1 2 2
6 1 1 2 2
7 11 11 1 2
8 11 11 1 2
9 111 111 11 1
10 111 111 111 111
AM
1b 2 1 2 1
2 2 1 2 2
3 2 2 2 2
4 2 1 2 2
5 2 2 2 2
6b 2 1 2 2
7c 1 1 2 2
8 2 2 2 2
9 2 1 2 2
10b 2 2 2 2
11c 2 2 2 2
12b 1 11 2 1
13b 2 11 2 2
14b 1 111 2 11
15b 111 2 1 2
TBMd
1 11 1 111 111
2 111 1 1 2
4 2 2 1 2
5 11 2 2 1
9 1 111 11 111
10 111 111 111 111
a Degrees of reactivity (A490) in serum: 2, ,0.2; 1, 0.2 to 0.5; 11, 0.5 to 1.0;
111, .1.0. Degrees of reactivity (A490) in CSF: 2, ,0.15; 1, 0.15 to 0.5; 11,
0.5 to 1.0; 111, .1.0. The cutoff points for seropositivity in serum and CSF
were 0.2 and 0.15, respectively, calculated as upper fourth 1 (2 3 interquartile
range).
b Patient with abnormally elevated AQ.
c Patient with abnormally elevated IgG synthesis rate.
d All patients with TBM had abnormally elevated IgG synthesis rates and AQ.
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majority of healthy patients carry high titers of humoral Ab to
M. tuberculosis Ag (3), which may diffuse into CSF through the
BBB, and the amount of diffused serum Ab may be even
greater in patients with forms of active meningitis associated
with the breakdown of the BBB. These assumptions suggest
that the demonstration of intrathecal synthesis of IgG in the
CNS and simultaneous measurement of M. tuberculosis-
specific Ab in CSF and serum are important for the correct
diagnosis of TBM. In this study, all patients with TBM showed
significant local synthesis of IgG and only 2 of 15 patients with
AM showed significant elevation in synthesis rates. Therefore,
AM seemed relatively weak in eliciting local humoral Ab pro-
duction, which was in agreement with the study of Kinnman et
al. (12).
In serological testing of CSF by ELISA, all six patients with
TBM showed positive reactivity to either PPD or LAM Ag. On
the other hand, 4 of 10 patients with PTBO showed positive
reactivity to PPD, and 2 of them were also seropositive for
LAM Ag. All these patients showed high titers of correspond-
ing Ab in their sera, while the remaining six patients, who were
negative for CSF Ab, showed relatively low titers of Ab in their
serum, which strongly suggested the diffusion of IgG Ab reac-
tive to PPD or LAM Ag from serum to CSF through an intact
BBB. In patients with AM, all 4 patients with reactivity to
either PPD or LAMAg in CSF had positive IgG titers in serum
in the low-to-high range and also showed abnormally elevated
AQ but normal ranges of IgG synthesis rates, which again
strengthens the argument for passive diffusion of IgG Ab
through a leaky BBB. Although our study was not designed to
directly demonstrate the diffusion of serum IgG Ab to CSF, the
results do clearly indicate that ELISA of CSF detects both
locally synthesized and passively diffused IgG Ab.
Previous clinical investigations which employed IgG Ab as-
says specific for various M. tuberculosis Ag showed quite vari-
able results, which was probably related to the differences in
control populations. In fact, the specificity of ELISA for PPD
and LAMAg in this study was much lower than in our previous
study (16), and this difference was related to the prevalence of
seropositivity in patients with AM. In our previous control
samples (from patients with AM), the rates of seropositivity in
serum and CSF were only 28 and 6.9%, respectively, compared
with 66.7 and 26.7%, respectively, in this sample. Therefore,
the appropriate interpretation of serological tests for the diag-
nosis of TBM should require the testing of both serum and
CSF. The presence of Ab in CSF without seroreactivity in
serum or higher titers of Ab in CSF than in serum may be
reliable evidence of TBM. On the other hand, simultaneous
detection of seroreactivity in both serum and CSF, but with
lower titers of Ab in CSF than in serum, should raise the
possibility of passive diffusion of Ab through the BBB. In our
study, the measurement of IgG synthesis rate appeared to be
potentially useful in differentiating TBM from AM, because all
10 patients with TBM showed significantly elevated IgG syn-
thesis rates, compared with only 2 of 15 patients with AM. The
combination of IgG synthesis rate measurement and ELISA
provided even better results, because all four AM patients with
false-positive reactivity in CSF had normal IgG synthesis rates.
However, an elevated IgG synthesis rate per se is not unique to
TBM, and it can also be seen in patients with other meningit-
ides, including fungal or bacterial meningitis, potentially lead-
ing to the administration of incorrect antimicrobial therapy.
For these reasons, we speculate that the techniques focusing
on detection of IgM Ab, which is much less diffusible than IgG
Ab, or M. tuberculosis-specific Ag may be more reasonable
alternatives for the early diagnosis of TBM, especially in areas
of highly endemic TB.
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